GLP-1 Market
LLY $1166.51 ▼ -1.4% NVO $38.06 ▼ -1.3% PFE $28.37 ▼ -0.1% VKTX $26.65 ▼ -6.0% KLRA $10.77 ▼ -4.9% GPCR $22.31 ▼ -6.7% RHHBY $53.77 ▼ -0.6%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Rifampin

Company
Children's Hospital of Philadelphia
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
43 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

43 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026

Find a Clinical Trial Near Me

See recruiting studies for Rifampin and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02539407

    Population Pharmacokinetics of Anti-infectives in Critically Ill Children

    Assistance Publique - Hôpitaux de Paris 3000 participants Est. completion 2028-12 1 site
    Other conditions: Pediatric Intensive Care Unit, Pediatric Immuno-hematology Department
    View official trial listing →
  • Recruiting NCT NCT03236987

    CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections

    Not yet reported Centre Hospitalier Universitaire, Amiens 424 participants Est. completion 2029-02-05 3 sites Stand-alone
    Other conditions: Lung Infection, MAC Lung Disease
    View official trial listing →
  • Recruiting NCT NCT03301038

    Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria

    Not yet reported Children's Hospital of Philadelphia 60 participants Est. completion 2030-12-01 1 site Stand-alone
    Other conditions: Idiopathic Infantile Hypercalcaemia - Severe Form, Genetic Disease, Hypercalcemia, Idiopathic, of Infancy, Hypercalciuric Hypercalcemia, Idiopathic Infantile Hypercalcemia - Mild Form, Hypercalciuria
    View official trial listing →
  • Recruiting NCT NCT03474029

    Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

    Not yet reported, Not yet reported Centers for Disease Control and Prevention 3400 participants Est. completion 2029-12-31 21 sites
    Other conditions: Latent Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT03625739

    Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis

    Beijing Children's Hospital 800 participants Est. completion 2026-12-31 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT04145258

    Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis

    Not yet reported ANRS, Emerging Infectious Diseases 768 participants Est. completion 2026-09-26 13 sites
    Other conditions: Tuberculous Meningitis
    View official trial listing →
  • Recruiting NCT NCT04921943

    Hypertonic Saline for MAC

    Not yet reported Oregon Health and Science University 50 participants Est. completion 2025-12-31 3 sites
    Other conditions: Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection
    View official trial listing →
  • Recruiting NCT NCT05069688

    Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin

    Not yet reported Brigham and Women's Hospital 20 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Pediatric HIV Infection, Tuberculosis Infection
    View official trial listing →
  • Recruiting NCT NCT05117788

    Bioneer Q-RFIA Clinical Evaluation

    Foundation for Innovative New Diagnostics, Switzerland 2350 participants Est. completion 2027-06-30 5 sites
    Other conditions: Tuberculosis, Multidrug-Resistant
    View official trial listing →
  • Recruiting NCT NCT05401071

    Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)

    Not yet reported, Not yet reported Huashan Hospital 2442 participants Est. completion 2027-11-01 6 sites
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Recruiting NCT NCT05473520

    Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis

    Not yet reported National University Hospital, Singapore 150 participants Est. completion 2030-01-31 6 sites Stand-alone
    Other conditions: Tuberculosis, Acute Coronary Syndrome, Pulmonary Hypertension (Diagnosis)
    View official trial listing →
  • Recruiting NCT NCT05534750

    Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

    Not yet reported Assistance Publique - Hôpitaux de Paris 60 participants Est. completion 2026-05 1 site
    Other conditions: Tuberculosis, Multidrug Resistant Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT05597280

    Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy

    Not yet reported Institute of Tropical Medicine, Belgium 124000 participants Est. completion 2027-03-15 1 site Stand-alone
    Other conditions: Leprosy
    View official trial listing →
  • Recruiting NCT NCT05821478

    Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients

    Not yet reported Institut Pasteur 92 participants Est. completion 2028-02-27 4 sites Stand-alone
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Recruiting NCT NCT05824871

    A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

    Not yet reported Shanghai Jiatan Pharmatech Co., Ltd 450 participants Est. completion 2026-10-22 2 sites
    Other conditions: Rifampin-Resistant Pulmonary Tuberculosis, Tuberculosis, Multidrug-Resistant (MDR-TB)
    View official trial listing →
  • Recruiting NCT NCT05902221

    Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections

    Not yet reported Centre Hospitalier Universitaire de Nice 235 participants Est. completion 2028-05 13 sites Stand-alone
    Other conditions: Infections Joint Prosthetic
    View official trial listing →
  • Recruiting NCT NCT06022146

    A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study)

    Not yet reported Huashan Hospital 3520 participants Est. completion 2026-09-01 66 sites
    Other conditions: Tuberculosis, Latent Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT06172010

    Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection

    Not yet reported Leiden University Medical Center 316 participants Est. completion 2028-03 13 sites
    Other conditions: Prosthetic-joint Infection, Infection Hip, Infection; Knee, Joint
    View official trial listing →
  • Recruiting NCT NCT06222372

    Novel Interventions and Diagnostic Tests for Leprosy

    Not yet reported Annemieke Geluk 1100 participants Est. completion 2026-12-15 1 site Stand-alone
    Other conditions: Leprosy
    View official trial listing →
  • Recruiting NCT NCT06253715

    Shortened Regimen for Drug-susceptible TB in Children

    Not yet reported Johns Hopkins University 860 participants Est. completion 2027-09-30 9 sites
    Other conditions: Tuberculosis, Tuberculosis, Pulmonary, Tuberculosis, Lymph Node, Mycobacterium Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT06403943

    Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis

    Not yet reported Beijing Chest Hospital 292 participants Est. completion 2026-12-31 1 site
    Other conditions: Adjuvant, Treatment, Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT06423898

    Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.

    Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 284 participants Est. completion 2028-12-31 18 sites
    Other conditions: Endocarditis, Infective
    View official trial listing →
  • Recruiting NCT NCT06446245

    Adjunctive Doxycycline for Central Nervous System Tuberculosis

    Not yet reported National University Hospital, Singapore 200 participants Est. completion 2027-12 6 sites Stand-alone
    Other conditions: Tuberculosis, Meningeal, Tuberculosis; Meningitis (Etiology), Tuberculosis, Central Nervous System, Tuberculosis; Meningoencephalitis (Etiology)
    View official trial listing →
  • Recruiting NCT NCT06497465

    Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

    Not yet reported Johns Hopkins University 150 participants Est. completion 2029-01-31 5 sites
    Other conditions: Tuberculosis, HIV
    View official trial listing →
  • Recruiting NCT NCT06498414

    Shorter and Safer Treatment Regimens for Latent TB

    Not yet reported, Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 1800 participants Est. completion 2029-06-01 14 sites Stand-alone
    Other conditions: Tuberculosis Infection, Latent
    View official trial listing →
  • Recruiting NCT NCT06585020

    Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection

    Not yet reported Centre Hospitalier Universitaire, Amiens 190 participants Est. completion 2027-08 1 site Stand-alone
    Other conditions: Mycobacterium; Xenopi, Lung Diseases
    View official trial listing →
  • Recruiting NCT NCT06727864

    Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial

    Not yet reported Kaohsiung Veterans General Hospital. 270 participants Est. completion 2028-12-31 8 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT06748937

    A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide

    Not yet reported TASK Applied Science 60 participants Est. completion 2026-03-30 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT06771050

    ROADMAP Clinical Trial

    Not yet reported University of Newcastle, Australia 2500 participants Est. completion 2029-12-31 43 sites
    Other conditions: Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee, Large Joint Prosthetic Joint Infections
    View official trial listing →
  • Recruiting NCT NCT06889701

    A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants

    Not yet reported, Not yet reported TenNor Therapeutics Inc. 33 participants Est. completion 2027-01 1 site Stand-alone
    Other conditions: Periprosthetic Joint Infection (PJI)
    View official trial listing →
  • Recruiting NCT NCT06905522

    A PAN-USR TB Multi-Center Trial

    Not yet reported Shenzhen Third People's Hospital 610 participants Est. completion 2029-12 3 sites
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT07014930

    Identification of New Tools for Predicting Natural Metabolic Performance of the Liver

    Not yet reported Caroline Samer 40 participants Est. completion 2026-01 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Recruiting NCT NCT07073638

    Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis

    Not yet reported Thirty Respiratory Limited 24 participants Est. completion 2026-11-15 1 site Stand-alone
    Other conditions: Pulmonary Tuberculoses
    View official trial listing →
  • Recruiting NCT NCT07084402

    Short-term Bactericidal Effect of Contezolid in MAC-PD

    Not yet reported Bin Cao 188 participants Est. completion 2027-12-31 3 sites Stand-alone
    Other conditions: Mycobacterium Avium Complex Pulmonary Disease
    View official trial listing →
  • Recruiting NCT NCT07303699

    ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)

    Not yet reported Obafemi Awolowo University Teaching Hospital 80 participants Est. completion 2028-03-30 3 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis (TB)
    View official trial listing →
  • Recruiting NCT NCT07313215

    Rifampin-combined Antibiotic Therapy for Staphylococcal PJI

    Not yet reported First Affiliated Hospital of Fujian Medical University 428 participants Est. completion 2027-12-18 1 site Stand-alone
    Other conditions: Periprosthetic Joint Infection
    View official trial listing →
  • Recruiting NCT NCT07345325

    Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditis

    Not yet reported Nantes University Hospital 422 participants Est. completion 2031-06-11 31 sites Stand-alone
    Other conditions: Infective Endocarditis
    View official trial listing →
  • Recruiting NCT NCT07374224

    A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet

    Not yet reported Guangzhou Lupeng Pharmaceutical Company LTD. 28 participants Est. completion 2026-08-30 1 site Stand-alone
    Other conditions: Clinical Pharmacology
    View official trial listing →
  • Recruiting NCT NCT07620041

    Phase I Study of QLC5508 in Advanced Solid Tumors: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug Interaction

    Not yet reported Qilu Pharmaceutical Co., Ltd. 48 participants Est. completion 2027-02-05 1 site Stand-alone
    Other conditions: Refractory or Relapsed Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT07788404

    Population Pharmacokinetic Model of Rifampicin in Staphylococcal Osteoarticular Infections

    Not yet reported Groupe Hospitalier Diaconesses Croix Saint-Simon 40 participants Est. completion 2029-06 1 site Stand-alone
    Other conditions: Prosthetic Joint Infection, Osteomyelitis, Staphylococcal Infections
    View official trial listing →
  • Recruiting NCT NCT07800897

    A Study of Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy Participants

    Not yet reported Bristol-Myers Squibb 80 participants Est. completion 2027-03-25 1 site Stand-alone
    Other conditions: Healthy Female Adults
    View official trial listing →
  • Recruiting NCT NCT07809815

    Drug-Drug Interaction Study of Befotertinib Capsules in Healthy Participants.

    Not yet reported Betta Pharmaceuticals Co., Ltd. 36 participants Est. completion 2027-05 1 site Stand-alone
    Other conditions: DDI (Drug-Drug Interaction)
    View official trial listing →
  • Recruiting NCT NCT07811518

    Latent Infection Freshmen Tracking for Tuberculosis

    Not yet reported Affiliated Hospital of Nantong University 3000 participants Est. completion 2029-08-31 2 sites
    Other conditions: Latent Tuberculosis Infection (LTBI), Tuberculosis (TB)
    View official trial listing →
  • Completed NCT NCT00000636

    Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 2000 participants Est. completion 1997-10 25 sites
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00000638

    Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 2000 participants Est. completion 1999-09 76 sites
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00000641

    A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 90 participants Est. completion 1994-12 16 sites
    Other conditions: Mycobacterium Avium-intracellulare Infection, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000796

    A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 525 participants Est. completion 1998-10 21 sites
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00000950

    Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 50 participants 13 sites
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00001033

    The Treatment of Tuberculosis in HIV-Infected Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 650 participants Est. completion 1997-07 12 sites
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00004689

    Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease

    Not yet reported National Jewish Health 50 participants Est. completion 1998-09
    Other conditions: Mycobacterium Avium-intracellulare Infection
    View official trial listing →
  • Completed NCT NCT00023335

    TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis

    Not yet reported Centers for Disease Control and Prevention 1000 participants Est. completion 2001-03 23 sites
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT00023374

    TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance

    Not yet reported Centers for Disease Control and Prevention 98 participants Est. completion 2010-12 23 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00042289

    Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

    National Institute of Allergy and Infectious Diseases (NIAID) 1578 participants Est. completion 2020-09-30 62 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00043264

    Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis

    Not yet reported National Center for Research Resources (NCRR) 40 participants 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00096850

    Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 18 participants Est. completion 2007-12 3 sites Stand-alone
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00108862

    Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 809 participants Est. completion 2010-07 26 sites Stand-alone
    Other conditions: HIV Infection, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00115609

    Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

    Not yet reported French National Agency for Research on AIDS and Viral Hepatitis 70 participants Est. completion 2009-11 1 site
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00128206

    Treatment of Latent TB Infection for Jailed Persons

    Not yet reported University of California, San Francisco 364 participants Est. completion 2009-09 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00182429

    Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment

    Not yet reported McMaster University 100 participants Est. completion 2005-12-31 4 sites
    Other conditions: Clostridium Enterocolitis, Antibiotic-Associated Diarrhea, Pseudomembranous Colitis, Pseudomembranous Enterocolitis, Pseudomembranous Enteritis
    View official trial listing →
  • Completed NCT NCT00201123

    Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs

    Not yet reported NYU Langone Health 89 participants Est. completion 2007-08 2 sites Stand-alone
    Other conditions: Tuberculosis, AIDS-related Complex
    View official trial listing →
  • Completed NCT NCT00279864

    The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection

    Mayo Clinic 15 participants Est. completion 2007-01 1 site
    Other conditions: Staphylococcal Infection, Staphylococcus Aureus Prosthetic Joint Infection
    View official trial listing →
  • Completed NCT NCT00286104

    Impact of Ventricular Catheter Used With Antimicrobial Agents on Patients With a Ventricular Catheter

    Not yet reported Chinese University of Hong Kong 184 participants Est. completion 2009-06 1 site
    Other conditions: Hydrocephalus, Intracranial Hypertension
    View official trial listing →
  • Completed NCT NCT00306319

    Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia

    Not yet reported Radboud University Medical Center 23 participants Est. completion 2006-05 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00317330

    A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 6400 participants Est. completion 2005-06 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00321178

    BURULICO Drug Trial Study Protocol: RCT SR8/SR4+CR4, GHANA

    Not yet reported, Not yet reported University Medical Center Groningen 151 participants Est. completion 2009-02 2 sites Stand-alone
    Other conditions: Buruli Ulcer, Mycobacterium Ulcerans
    View official trial listing →
  • Terminated NCT NCT00322907

    Cotrifazid Safety and Efficacy Against Malaria

    Not yet reported Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland 330 participants Est. completion 2003-01 1 site
    Other conditions: Clinical Malaria
    View official trial listing →
  • Completed NCT NCT00351273

    Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria

    Not yet reported University of South Florida 42 participants Est. completion 2008-09 3 sites
    Other conditions: Arthritis, Reactive, Reiter Disease
    View official trial listing →
  • Completed NCT NCT00367913

    Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease

    Not yet reported British Thoracic Society 400 participants Est. completion 2004-09 1 site
    Other conditions: Pulmonary Diseases
    View official trial listing →
  • Terminated NCT NCT00370149

    Study of Catheter-related Infections Using Antibiotic-coated Versus Conventional Catheters in Children

    Not yet reported Indiana University 326 participants Est. completion 2010-05 1 site
    Other conditions: Infection Prevention
    View official trial listing →
  • Status unknown NCT NCT00376012

    Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis

    Not yet reported Tuberculosis Research Centre, India 300 participants Est. completion 2008-09 1 site Stand-alone
    Other conditions: Tuberculosis, Human Immunodeficiency Virus Infections
    View official trial listing →
  • Completed NCT NCT00384280

    Study to Determine the Impact of Multiple Doses of Rifampin on Single-dose Pharmacokinetics of HCV-796

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 24 participants Est. completion 2006-11
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00397709

    Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection

    Not yet reported Hospital Virgen de la Luz 228 participants Est. completion 2006-02 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00402610

    A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy

    Not yet reported Sociedad Andaluza de Enfermedades Infecciosas 332 participants Est. completion 1998-12 1 site
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00405080

    A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).

    Not yet reported GlaxoSmithKline 12 participants Est. completion 2007-01-05 1 site Stand-alone
    Other conditions: Nausea and Vomiting, Chemotherapy-Induced
    View official trial listing →
  • Completed NCT NCT00405301

    Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage

    Not yet reported All India Institute of Medical Sciences 175 participants Est. completion 2008-12 2 sites
    Other conditions: Drug Induced Hepatotoxicity, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00411996

    The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

    Not yet reported, Not yet reported The HIV Netherlands Australia Thailand Research Collaboration 20 participants Est. completion 2009-12 1 site
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00418756

    Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects

    Not yet reported Novartis Pharmaceuticals 12 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00419172

    Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in Healthy Volunteers

    Not yet reported Novartis 22 participants
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT00474435

    Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis

    Not yet reported African Poverty Related Infection Oriented Research Initiative 30 participants Est. completion 2009-12 1 site
    Other conditions: Tuberculosis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00476853

    Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

    Not yet reported The HIV Netherlands Australia Thailand Research Collaboration 42 participants Est. completion 2009-12 6 sites
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00483054

    Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

    Not yet reported Bamrasnaradura Infectious Diseases Institute 142 participants Est. completion 2010-12 1 site
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00495326

    Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)

    Not yet reported, Not yet reported French National Agency for Research on AIDS and Viral Hepatitis 570 participants Est. completion 2011-04 3 sites Stand-alone
    Other conditions: Tuberculosis, Aids, Hiv Infections
    View official trial listing →
  • Terminated NCT NCT00523458

    A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV

    Not yet reported Stanford University 5 participants Est. completion 2008-03 1 site Stand-alone
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Terminated NCT NCT00533390

    Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg

    Not yet reported Oswaldo Cruz Foundation 130 participants Est. completion 2012-10 2 sites Stand-alone
    Other conditions: Tuberculosis, HIV Infections
    View official trial listing →
  • Withdrawn NCT NCT00534807

    A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer

    Not yet reported Bristol-Myers Squibb Est. completion 2008-11 1 site
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT00548002

    Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia

    University of Helsinki 430 participants Est. completion 2002-08 1 site
    Other conditions: Staphylococcus Aureus, Bacteremia, Endocarditis, Sepsis
    View official trial listing →
  • Completed NCT NCT00585195

    A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

    Not yet reported Pfizer 596 participants Est. completion 2022-01-19 29 sites Stand-alone
    Other conditions: Non-Small Cell Lung Cancer ALK-positive, Non-Small Cell Lung Cancer c-Met Dependent, Non-Small Cell Lung Cancer ROS Marker Positive, Systemic Anaplastic Large-Cell Lymphoma, Advanced Malignancies Except Leukemia
    View official trial listing →
  • Completed NCT NCT00598897

    Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease

    Not yet reported The University of Texas Health Science Center at Tyler 89 participants Est. completion 2017-05-18 1 site Stand-alone
    Other conditions: Mycobacterium Avium Complex Lung Disease
    View official trial listing →
  • Completed NCT NCT00608907

    An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)

    Not yet reported Millennium Pharmaceuticals, Inc. 61 participants Est. completion 2010-04 9 sites Stand-alone
    Other conditions: Multiple Myeloma, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00617643

    Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis

    Not yet reported Makerere University 18 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT00620438

    Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients

    Not yet reported Makerere University 90 participants Est. completion 2011-07 1 site Stand-alone
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00621309

    Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions

    Not yet reported University of Washington 29 participants Est. completion 2010-09 2 sites
    Other conditions: Adverse Drug Interactions
    View official trial listing →
  • Completed NCT NCT00669643

    Uniform Multidrug Therapy Regimen for Leprosy Patients

    Not yet reported University of Brasilia 859 participants Est. completion 2016-12-31 2 sites Stand-alone
    Other conditions: Leprosy
    View official trial listing →
  • Completed NCT NCT00694629

    TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment

    Not yet reported Centers for Disease Control and Prevention 334 participants Est. completion 2013-12 29 sites
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT00698334

    Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis

    Not yet reported All India Institute of Medical Sciences 150 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: HIV Infections, Acquired Immunodeficiency Syndrome, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00703898

    Durability of Nevirapine-Based Antiretroviral Regimen

    Not yet reported Bamrasnaradura Infectious Diseases Institute 140 participants Est. completion 2010-04 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00711854

    Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection

    Not yet reported University Hospital, Geneva 150 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: MRSA Infection
    View official trial listing →
  • Completed NCT NCT00720980

    Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy

    Henry Ford Health System 6 participants Est. completion 2008-07 1 site
    Other conditions: Granuloma Annulare
    View official trial listing →
  • Terminated NCT NCT00728507

    Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis

    Not yet reported Johns Hopkins University 121 participants Est. completion 2013-04 3 sites
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00741169

    TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing.

    Not yet reported Tibotec Pharmaceuticals, Ireland 21 participants Est. completion 2008-12 Stand-alone
    Other conditions: Hepatitis C, HCV, Tuberculosis, Rifampin, Pharmacokinetics
    View official trial listing →
  • Active, not recruiting NCT NCT00750841

    Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours

    Not yet reported AstraZeneca 64 participants Est. completion 2026-12-31 6 sites Stand-alone
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT00760149

    Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis

    Not yet reported Radboud University Medical Center 150 participants Est. completion 2013-09 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00767975

    Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison

    Not yet reported National Taiwan University Hospital 2384 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00776516

    Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers

    Not yet reported Astellas Pharma Inc 24 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Pharmacokinetics of YM178
    View official trial listing →
  • Completed NCT NCT00816426

    Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 19 participants Est. completion 2017-12-29 3 sites
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00822315

    Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

    Not yet reported ANRS, Emerging Infectious Diseases 155 participants Est. completion 2012-05 9 sites
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00834353

    Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis

    Maulana Azad Medical College Est. completion 2008-09 1 site
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT00856752

    Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and Cyclosporine

    Not yet reported Norgine 12 participants Est. completion 2006-08 1 site Stand-alone
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00864383

    Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis

    Not yet reported Global Alliance for TB Drug Development 1931 participants Est. completion 2014-02 47 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT00864487

    Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib

    Not yet reported Puma Biotechnology, Inc. 24 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00877591

    Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

    Not yet reported University of California, San Francisco 63 participants Est. completion 2013-04 1 site Stand-alone
    Other conditions: Opioid Dependency, HIV Infections
    View official trial listing →
  • Completed NCT NCT00929786

    Anti-tuberculosis (TB) Drug Levels and Hepatotoxicity

    All India Institute of Medical Sciences 72 participants Est. completion 2009-06 2 sites
    Other conditions: Hepatitis, Tuberculosis
    View official trial listing →
  • Completed NCT NCT00933790

    Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis

    Not yet reported Tuberculosis Research Centre, India 331 participants Est. completion 2018-06-30 3 sites Stand-alone
    Other conditions: HIV Infection, Pulmonary TB
    View official trial listing →
  • Withdrawn NCT NCT00935363

    Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK)

    Not yet reported University of California, San Francisco Est. completion 2010-04 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00938262

    A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

    Not yet reported Boryung Pharmaceutical Co., Ltd 24 participants Est. completion 2009-08 Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00955760

    Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate

    Not yet reported Merz Pharmaceuticals GmbH Est. completion 2009-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00985270

    Pregnane X Receptor (PXR) Agonist Rifampicin Effects on Glucose, Lipid and Hormone Homeostasis

    Not yet reported University of Oulu 12 participants Est. completion 2010-10 1 site
    Other conditions: Glucose Tolerance
    View official trial listing →
  • Completed NCT NCT01018368

    Study of VX-770 and Rifampin in Healthy Male Subjects

    Not yet reported Vertex Pharmaceuticals Incorporated 24 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT01026714

    CYP2C9 Activity Evaluated With a Simple Finger Prick

    Not yet reported, Not yet reported University Hospital, Geneva 10 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01029717

    CATCH - Catheter Infections in Children

    Not yet reported Institute of Child Health 1859 participants Est. completion 2012-11 1 site
    Other conditions: Catheter-related Infections
    View official trial listing →
  • Terminated NCT NCT01068756

    Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects

    Not yet reported AstraZeneca 14 participants Est. completion 2010-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01082276

    Rifampin Drug-Drug Interaction Study With Lurasidone HCl

    Not yet reported Sumitomo Pharma America, Inc. 20 participants Est. completion 2008-08 1 site
    Other conditions: Male, Healthy Normal Subjects
    View official trial listing →
  • Completed NCT NCT01138202

    Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

    Not yet reported The HIV Netherlands Australia Thailand Research Collaboration 40 participants Est. completion 2015-12 1 site
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT01144000

    Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection

    Not yet reported Andrej Trampuz 60 participants Est. completion 2016-06 3 sites Stand-alone
    Other conditions: Staphylococcal Infections
    View official trial listing →
  • Completed NCT NCT01147055

    Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers

    Not yet reported Pfizer 15 participants Est. completion 2010-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01154959

    Latency in Pulmonary Tuberculosis

    Not yet reported Tuberculosis Research Centre, India 120 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT01158755

    Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study

    Not yet reported Universitas Padjadjaran 60 participants Est. completion 2012-06 1 site
    Other conditions: Meningitis, Tuberculous, Pharmacokinetics, Pharmacodynamics, Tolerability
    View official trial listing →
  • Completed NCT NCT01162486

    Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers

    Not yet reported Johns Hopkins University 37 participants Est. completion 2011-03 1 site
    Other conditions: Tuberculosis, Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT01169038

    Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis

    Not yet reported Vanderbilt University 15 participants Est. completion 2010-11 1 site
    Other conditions: Pulmonary Sarcoidosis, Lung Function
    View official trial listing →
  • Completed NCT NCT01204112

    Estimate The Effect Of Repeat-Dose Rifampin On The Pharmacokinetics Of CP-690,550 In Healthy Volunteers

    Not yet reported Pfizer 12 participants Est. completion 2010-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01215851

    Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)

    Not yet reported Global Alliance for TB Drug Development 85 participants Est. completion 2011-08 2 sites
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT01222338

    Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

    Not yet reported Lisichansk Regional Tuberculosis Dispensary 123 participants Est. completion 2011-01 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT01225640

    PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay

    Not yet reported Sequella, Inc. 59 participants Est. completion 2011-12 2 sites
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT01231542

    Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers

    Not yet reported ViiV Healthcare 27 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Infection, Human Immunodeficiency Virus
    View official trial listing →
  • Completed NCT NCT01269541

    MESS-study MRSA Eradication Study Skåne

    Not yet reported Region Skane 69 participants Est. completion 2015-05-01 6 sites
    Other conditions: Throatcarriers of MRSA
    View official trial listing →
  • Completed NCT NCT01273480

    A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

    Not yet reported Janssen Research & Development, LLC 12 participants Est. completion 2012-10 2 sites Stand-alone
    Other conditions: Neoplasm Metastases
    View official trial listing →
  • Terminated NCT NCT01287221

    Study of Rifampicin in Multiple System Atrophy

    Not yet reported Phillip Low 100 participants Est. completion 2013-01 10 sites
    Other conditions: Multiple System Atrophy
    View official trial listing →
  • Status unknown NCT NCT01297855

    Colistin Plus Rifampicin in MDR P. Aeruginosa and A. Baumanii

    Not yet reported Mahidol University 130 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Drug Safety
    View official trial listing →
  • Completed NCT NCT01311505

    Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®)

    Not yet reported Pfizer 21 participants Est. completion 2011-05 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT01315301

    Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis

    Not yet reported Karolinska Institutet 450 participants Est. completion 2012-03 1 site
    Other conditions: Acquired Immunodeficiency Syndrome, Tuberculosis
    View official trial listing →
  • Completed NCT NCT01322438

    Effect of Rifampin on the Pharmacokinetics of BAY73-4506

    Not yet reported Bayer 24 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT01323465

    Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex

    Not yet reported Jazz Pharmaceuticals 36 participants Est. completion 2008-03 1 site Stand-alone
    Other conditions: Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4, Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4, Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19 Inhibitor
    View official trial listing →
  • Completed NCT NCT01324323

    Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer

    Not yet reported Celgene 14 participants Est. completion 2012-03-01 3 sites Stand-alone
    Other conditions: Hematologic Malignancy, Malignant Lymphoma
    View official trial listing →
  • Terminated NCT NCT01329250

    Pharmacokinetics and Safety of Moxifloxacin

    Not yet reported University Medical Center Groningen 9 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT01340456

    Cholesterol Metabolites as Markers for CYP3A Induction

    Not yet reported Karolinska University Hospital 24 participants Est. completion 2011-07 1 site Stand-alone
    Other conditions: CYP3A4 Induction
    View official trial listing →
  • Completed NCT NCT01341184

    TMC207 +/- Rifabutin/Rifampin

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 33 participants Est. completion 2012-05-23 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Terminated NCT NCT01349192

    Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)

    Not yet reported University of North Carolina, Chapel Hill 47 participants Est. completion 2015-05 13 sites Stand-alone
    Other conditions: Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus
    View official trial listing →
  • Completed NCT NCT01364324

    Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients

    National Cancer Center, Korea 40 participants Est. completion 2020-06 1 site
    Other conditions: Tuberculosis, Tuberculosis, Pulmonary, Early Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01380080

    REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 851 participants Est. completion 2016-04 18 sites Stand-alone
    Other conditions: HIV Infection
    View official trial listing →
  • Completed NCT NCT01386593

    Pharmacokinetic Study to Characterize Phenotyping Metrics of the "Basel" Cocktail After CYP Induction or Inhibition

    Not yet reported University Hospital, Basel, Switzerland 16 participants Est. completion 2012-01 1 site
    Other conditions: Metabolic Detoxication, Phase I
    View official trial listing →
  • Status unknown NCT NCT01388075

    Genetic Variability in the Response to Warfarin at Baseline and During Induction of CYP2C9

    Not yet reported Hadassah Medical Organization 150 participants 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT01392911

    Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB

    Not yet reported Radboud University Medical Center 128 participants Est. completion 2018-11 2 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis (TB)
    View official trial listing →
  • Completed NCT NCT01395927

    A Study to Evaluate the Effects of Rifampin on Single-Dose Pharmacokinetics of Canagliflozin in Healthy Volunteers

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 14 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01396265

    Drug Interaction Study With Rifampicin and Afatinib

    Not yet reported Boehringer Ingelheim 22 participants 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01406002

    To Evaluate if Multiple Doses of Rifampicin Change the Blood Concentration of YM150 (Darexaban)

    Not yet reported Astellas Pharma Inc 26 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Pharmacokinetics of Darexaban and Metabolites, Healthy Subjects
    View official trial listing →
  • Completed NCT NCT01438515

    Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization

    Not yet reported Horizon Health Network 100 participants Est. completion 2019-12-31 1 site Stand-alone
    Other conditions: Methicillin-resistant Staphylococcus Aureus
    View official trial listing →
  • Terminated NCT NCT01441206

    Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants

    Not yet reported University of North Carolina, Chapel Hill 2 participants Est. completion 2012-04 1 site
    Other conditions: Infection
    View official trial listing →
  • Completed NCT NCT01447511

    Pharmacogenetics of Warfarin Induction and Inhibition

    Not yet reported University of Minnesota 39 participants Est. completion 2013-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01454076

    Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma

    Not yet reported Millennium Pharmaceuticals, Inc. 112 participants Est. completion 2016-06-16 1 site Stand-alone
    Other conditions: Nonhematologic Malignancies, Lymphoma
    View official trial listing →
  • Completed NCT NCT01456845

    Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity

    All India Institute of Medical Sciences 110 participants Est. completion 2012-06 1 site
    Other conditions: Hepatitis, Tuberculosis
    View official trial listing →
  • Completed NCT NCT01500837

    Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)

    Not yet reported Assistance Publique - Hôpitaux de Paris 23 participants Est. completion 2011-10 1 site
    Other conditions: Osteoarticular Infection
    View official trial listing →
  • Completed NCT NCT01516203

    Phase 2a EBA Trial of AZD5847

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 75 participants Est. completion 2013-12-24 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT01561963

    A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast

    Not yet reported Amgen 21 participants Est. completion 2012-04-01 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT01577862

    Colistin and Rifampicin for MDR-Acinetobacter

    Not yet reported University of Campania Luigi Vanvitelli 210 participants Est. completion 2011-10 Stand-alone
    Other conditions: Infection Due to Resistant Bacteria, Pneumonia, Ventilator-Associated, Hospital Acquired Pneumonia, Infection of Bloodstream, Infectious Disease of Abdomen
    View official trial listing →
  • Completed NCT NCT01589497

    Essentiality of INH in TB Therapy

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 69 participants Est. completion 2016-02-10 2 sites
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT01591850

    A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers

    Not yet reported Hoffmann-La Roche 51 participants Est. completion 2011-11 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01594827

    Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)

    Not yet reported Johns Hopkins University 29 participants Est. completion 2017-12-30 2 sites Stand-alone
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT01634100

    Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and Probenecid

    Not yet reported Boehringer Ingelheim 18 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01637636

    Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin.

    Not yet reported Vanda Pharmaceuticals 48 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01655147

    A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male Participants

    Not yet reported Janssen Research & Development, LLC 19 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01677871

    Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease

    Not yet reported Institute of Liver and Biliary Sciences, India 120 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Chronic Liver Disease With Tuberclosis
    View official trial listing →
  • Completed NCT NCT01679639

    A Study to Investigate the Effects of Rifampicin on the Pharmacokinetics of Aleglitazar in Healthy Volunteers

    Not yet reported Hoffmann-La Roche 24 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01690104

    The Effect of PXR Activation on Blood Pressure Regulation

    Not yet reported University of Oulu 22 participants Est. completion 2013-12 1 site
    Other conditions: Blood Pressure Regulation
    View official trial listing →
  • Status unknown NCT NCT01699633

    Rifampin and Nevirapine Interactions in Young Children

    The Miriam Hospital 58 participants Est. completion 2017-05 1 site
    Other conditions: Tuberculosis, HIV
    View official trial listing →
  • Status unknown NCT NCT01704144

    Rifampin and Efavirenz Interactions in Older Children

    The Miriam Hospital 160 participants Est. completion 2017-05 1 site
    Other conditions: HIV, Tuberculosis
    View official trial listing →
  • Completed NCT NCT01728363

    Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)

    Not yet reported Phillip Brian Smith 63 participants Est. completion 2015-05 10 sites Stand-alone
    Other conditions: Systemic Infection
    View official trial listing →
  • Completed NCT NCT01751568

    Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 40 participants Est. completion 2019-11-27 4 sites Stand-alone
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Terminated NCT NCT01756924

    Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection

    Not yet reported Arrevus Inc. 14 participants Est. completion 2014-07 13 sites Stand-alone
    Other conditions: Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee, Infected Spacers
    View official trial listing →
  • Status unknown NCT NCT01757236

    Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection

    Not yet reported University Hospital, Tours 100 participants Est. completion 2016-04 9 sites Stand-alone
    Other conditions: Hip Prosthetic Joint Infection
    View official trial listing →
  • Completed NCT NCT01760642

    Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity

    Not yet reported Seoul National University Hospital 16 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01763021

    A Study to Assess the Effect of Rifampin on the Pharmacokinetics of PCI-32765 in Healthy Participants

    Not yet reported Janssen Research & Development, LLC 18 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT01765543

    A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)

    Not yet reported Hoffmann-La Roche 27 participants Est. completion 2015-11 15 sites Stand-alone
    Other conditions: Malignant Melanoma, Neoplasms
    View official trial listing →
  • Completed NCT NCT01768663

    A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects

    Not yet reported Vertex Pharmaceuticals Incorporated 80 participants 1 site Stand-alone
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Status unknown NCT NCT01782950

    Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes

    Not yet reported Makerere University 400 participants Est. completion 2016-03 1 site
    Other conditions: AIDS With Tuberculosis
    View official trial listing →
  • Completed NCT NCT01785186

    Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design

    Not yet reported Michael Hoelscher 365 participants Est. completion 2015-03 7 sites Stand-alone
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Status unknown NCT NCT01785927

    The Safety of Tuberculosis Treatments by Oral Inhalation

    Not yet reported Prince of Songkla University 40 participants Est. completion 2013-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01802502

    Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation

    Not yet reported Universitas Padjadjaran 30 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Tuberculous Meningitis
    View official trial listing →
  • Completed NCT NCT01805258

    Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB

    Not yet reported All India Institute of Medical Sciences 135 participants Est. completion 2013-02 1 site Stand-alone
    Other conditions: HIV/TB Co-infection
    View official trial listing →
  • Completed NCT NCT01814709

    A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy Volunteers

    Not yet reported Genentech, Inc. 32 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01844583

    Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib

    Not yet reported Millennium Pharmaceuticals, Inc. 55 participants Est. completion 2016-09-06 7 sites Stand-alone
    Other conditions: Solid Tumors, Lymphoma
    View official trial listing →
  • Completed NCT NCT01845298

    Immune Activation and Drug Absorption in HIV-Infected Patients

    Not yet reported Drexel University 7 participants Est. completion 2016-03-14 1 site Stand-alone
    Other conditions: HIV Infection
    View official trial listing →
  • Completed NCT NCT01854489

    Effects of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sublingual and Intravenous Buprenorphine

    Not yet reported Turku University Hospital 12 participants Est. completion 2014-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01908582

    A Study of Evacetrapib and Rifampin in Healthy Participants

    Not yet reported Eli Lilly and Company 26 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01910311

    A Study of Baricitinib and Rifampicin in Healthy Participants

    Not yet reported Eli Lilly and Company 18 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01929603

    Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours

    Not yet reported AstraZeneca 32 participants Est. completion 2016-11 5 sites Stand-alone
    Other conditions: Solid Tumours
    View official trial listing →
  • Completed NCT NCT01947777

    Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145

    Not yet reported SecuraBio 14 participants Est. completion 2013-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01950364

    A Phase 1 Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma

    Not yet reported Millennium Pharmaceuticals, Inc. 20 participants Est. completion 2015-06 6 sites Stand-alone
    Other conditions: Hodgkin Lymphoma, Anaplastic Large-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01953731

    A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991)

    Not yet reported Pfizer 15 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01960257

    Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis

    Not yet reported University of California, San Diego 92 participants Est. completion 2017-01-31 2 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Withdrawn NCT NCT01969682

    A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199

    Not yet reported AbbVie Est. completion 2014-05 1 site Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01970605

    Silver Graft All Comers Registry

    B. Braun Melsungen AG 230 participants Est. completion 2018-12 1 site
    Other conditions: Aneurysm, Graft Failure, Graft Infection
    View official trial listing →
  • Status unknown NCT NCT01986543

    Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection

    Not yet reported ANRS, Emerging Infectious Diseases 105 participants Est. completion 2017-12 1 site
    Other conditions: Tuberculosis, HIV
    View official trial listing →
  • Status unknown NCT NCT01994460

    Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis

    Not yet reported Seoul National University Hospital 429 participants Est. completion 2016-06 3 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis Without Resistance to Rifampicin
    View official trial listing →
  • Completed NCT NCT02014272

    A Bioequivalence Study Comparing A Fixed Dose Combination Formulation, Rin 150 And Individual Reference Drugs In Healthy Volunteers

    Not yet reported Pfizer 28 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02019875

    CYP3A4 Activity and Mineral Homeostasis

    Not yet reported University of Washington 92 participants Est. completion 2020-12 1 site
    Other conditions: Vitamin D and Calcium Homeostasis
    View official trial listing →
  • Completed NCT NCT02024555

    Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis

    Not yet reported Vanderbilt University 97 participants Est. completion 2019-04-01 6 sites
    Other conditions: Sarcoidosis; Antimycobacterial Therapy
    View official trial listing →
  • Completed NCT NCT02046850

    To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers

    Not yet reported AstraZeneca 24 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Solid Tumours
    View official trial listing →
  • Completed NCT NCT02057796

    Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3

    Not yet reported ANRS, Emerging Infectious Diseases 1050 participants Est. completion 2018-04 4 sites Stand-alone
    Other conditions: HIV-1 Infection
    View official trial listing →
  • Completed NCT NCT02085967

    A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion

    Not yet reported Eisai Inc. 106 participants Est. completion 2014-06 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Terminated NCT NCT02099240

    Patients Response to Early Switch To Oral:Osteomyelitis Study

    Not yet reported Julio Ramirez 11 participants Est. completion 2018-11-07 1 site
    Other conditions: Osteomyelitis
    View official trial listing →
  • Completed NCT NCT02106767

    The Effects of Rifampin on the Pharmacokinetics of Rosuvastatin

    Not yet reported University of California, San Francisco 16 participants Est. completion 2016-08-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02114684

    Improving Retreatment Success (IMPRESS)

    Not yet reported, Not yet reported Centre for the AIDS Programme of Research in South Africa 197 participants Est. completion 2017-07-17 1 site
    Other conditions: Recurrent Tuberculosis
    View official trial listing →
  • Completed NCT NCT02121314

    HRZE Fasted/Fed in Newly Diagnosed TB

    Not yet reported University Medical Center Groningen 20 participants Est. completion 2014-06 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT02123628

    Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis

    Not yet reported Tourcoing Hospital 40 participants Est. completion 2012-09 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02138799

    A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men

    Not yet reported Astellas Pharma Europe B.V. 28 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Drug-Drug Interaction (DDI), Healthy Subjects, Pharmacokinetics of Enzalutamide
    View official trial listing →
  • Completed NCT NCT02153528

    Optimization of the TB Treatment Regimen Cascade

    Not yet reported Damien Foundation 701 participants Est. completion 2017-08-01 1 site Stand-alone
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT02174250

    The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.

    Not yet reported Kyowa Kirin Co., Ltd. 20 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02183584

    Study to Evaluate the Effect of Multiple Doses of Rifampicin on the Multiple-dose Pharmacokinetics of Linagliptin in Healthy Volunteers

    Not yet reported Boehringer Ingelheim 16 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02193776

    A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.

    Not yet reported Global Alliance for TB Drug Development 240 participants Est. completion 2018-02-07 10 sites
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT02197247

    Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

    Not yet reported AstraZeneca 41 participants Est. completion 2021-05-26 18 sites Stand-alone
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT02199392

    A Pharmacokinetic Study to Assess the Influence of P-glycoprotein Inhibition and Simultaneous CYP3A4 and P-glycoprotein Induction on E7080 Pharmacokinetics Following Single Dose Oral Administration of 24 mg E7080 to Healthy Volunteers

    Not yet reported Eisai Inc. 15 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: P-glycoprotein, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02216331

    PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)

    Not yet reported Global Alliance for TB Drug Development 32 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT02231229

    Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation

    Not yet reported Assistance Publique - Hôpitaux de Paris 204 participants Est. completion 2020-02-18 2 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT02251327

    Feasibility and Accuracy of a Novel Xpert Cartridge

    Johns Hopkins University 401 participants Est. completion 2015-12
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT02253420

    COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients

    Not yet reported Bayer 51 participants Est. completion 2019-08-13 5 sites Stand-alone
    Other conditions: Medical Oncology
    View official trial listing →
  • Completed NCT NCT02256267

    A Study of LY2835219 in Healthy Participants

    Not yet reported Eli Lilly and Company 24 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02256696

    Assessing PA-824 for Tuberculosis (the APT Trial)

    Not yet reported Johns Hopkins University 157 participants Est. completion 2022-05-01 1 site Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT02275962

    Drug-Drug Interaction Study in Healthy Adult Volunteers

    Not yet reported Kowa Research Institute, Inc. 20 participants Est. completion 2015-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02286635

    Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of Deflazacort

    Not yet reported PTC Therapeutics 58 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02313610

    Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis

    Not yet reported Shanghai University of Traditional Chinese Medicine 253 participants Est. completion 2013-03 12 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT02328443

    Evaluation and Validation of Metabolic Markers for the Assessment of CYP3A Activity and Prediction of DDI

    Not yet reported Seoul National University Hospital 24 participants Est. completion 2015-04 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02329405

    The Effects of PXR Activation on Hepatic Fat Content

    Not yet reported University of Oulu 16 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Status unknown NCT NCT02331823

    Research on New Regimens for Retreatment Pulmonary Tuberculosis

    Not yet reported Shanghai Pulmonary Hospital, Shanghai, China 864 participants Est. completion 2016-12 1 site
    Other conditions: Reinfection Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT02381470

    Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers

    Not yet reported National University Hospital, Singapore 58 participants Est. completion 2019-10-02 6 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT02383849

    IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants

    International Maternal Pediatric Adolescent AIDS Clinical Trials Group 124 participants Est. completion 2020-02-14 2 sites
    Other conditions: Low-Birth-Weight Infant, Tuberculosis, HIV
    View official trial listing →
  • Suspended NCT NCT02387242

    Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers

    Not yet reported National University Hospital, Singapore 18 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT02410772

    TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens

    Not yet reported Centers for Disease Control and Prevention 2516 participants Est. completion 2021-05 33 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT02411435

    Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects

    Not yet reported ViiV Healthcare 15 participants Est. completion 2015-09 1 site
    Other conditions: Infection, Human Immunodeficiency Virus
    View official trial listing →
  • Completed NCT NCT02412436

    PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 62 participants Est. completion 2017-06-15 5 sites Stand-alone
    Other conditions: HIV-1 Infection, Tuberculosis
    View official trial listing →
  • Completed NCT NCT02430545

    Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib Pharmacokinetics

    Not yet reported Pfizer 12 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02440841

    Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon

    Not yet reported Vantia Ltd 29 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Nocturia
    View official trial listing →
  • Status unknown NCT NCT02477852

    The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis

    Not yet reported Beijing Chest Hospital 400 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Tuberculosis, Spinal
    View official trial listing →
  • Completed NCT NCT02545439

    A Drug-drug Interaction Study of ALKS 5461 in Healthy Volunteers

    Not yet reported Alkermes, Inc. 24 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02554318

    Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia

    Not yet reported University of Giessen 147 participants Est. completion 2015-02 Stand-alone
    Other conditions: Pulmonary Tuberculosis, Body Weight Changes, Motor Activity
    View official trial listing →
  • Completed NCT NCT02576366

    Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus

    Not yet reported Universitaire Ziekenhuizen KU Leuven 24 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Drug Interactions, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02581527

    A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis

    Not yet reported St George's, University of London 672 participants Est. completion 2022-07-31 6 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT02597621

    Biomarkers for Therapy Response in Drug-resistant Tuberculosis

    Research Center Borstel 192 participants Est. completion 2021-01 1 site
    Other conditions: Tuberculosis, Multidrug-resistant
    View official trial listing →
  • Completed NCT NCT02599493

    EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin

    Not yet reported Rennes University Hospital 544 participants Est. completion 2020-12 16 sites Stand-alone
    Other conditions: Osteoarticular Infection
    View official trial listing →
  • Completed NCT NCT02602509

    Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers

    Not yet reported National University Hospital, Singapore 18 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT02608034

    A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State

    Not yet reported Genentech, Inc. 32 participants Est. completion 2018-09-10 11 sites Stand-alone
    Other conditions: Metastatic Melanoma, BRAF V600 Mutation Positive
    View official trial listing →
  • Completed NCT NCT02661893

    A Drug Interaction Study in Healthy Participants to Assess the Effect of Rifampin on the Pharmacokinetics of JNJ-42847922

    Not yet reported Janssen Research & Development, LLC 14 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02684240

    A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis

    Not yet reported Weill Medical College of Cornell University 30 participants Est. completion 2018-04-11 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT02691962

    Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias

    Not yet reported C. R. Bard 75 participants Est. completion 2020-05 11 sites Stand-alone
    Other conditions: Incisional Hernia
    View official trial listing →
  • Completed NCT NCT02701608

    Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus

    Not yet reported University Hospital, Tours 162 participants Est. completion 2024-12-04 45 sites Stand-alone
    Other conditions: Infective Endocarditis
    View official trial listing →
  • Completed NCT NCT02729467

    A Study to Assess the Effects of Itraconazole and Rifampicin on the Single-Dose Pharmacokinetics of JNJ-53718678 in Healthy Adults

    Not yet reported Janssen Research & Development, LLC 33 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02770222

    A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects

    Not yet reported Actelion 40 participants Est. completion 2016-07 Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02774993

    Doxycycline in Human Pulmonary Tuberculosis

    Not yet reported National University Hospital, Singapore 40 participants Est. completion 2017-06 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT02776150

    Probe Melting Technology for Rapid Detection of Drug Resistant Tuberculosis

    Beijing Hospital 3100 participants Est. completion 2019-06
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT02782078

    Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular Infections

    Not yet reported Assistance Publique - Hôpitaux de Paris 20 participants Est. completion 2019-01-03 1 site
    Other conditions: Staphylococcal Infections
    View official trial listing →
  • Completed NCT NCT02804399

    A Study To Evaluate The Effect Of Rifampin On Pharmacokinetics Of PF-06463922 In Healthy Volunteers

    Not yet reported Pfizer 12 participants Est. completion 2016-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02807116

    Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects

    Not yet reported CTI BioPharma 18 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02808507

    Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa

    Not yet reported Johns Hopkins Bloomberg School of Public Health 4852 participants Est. completion 2020-01-30 2 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT02809768

    Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy Subjects

    Not yet reported Eisai Inc. 48 participants Est. completion 2016-09 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT02820935

    Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of CC-220 in Healthy Subjects

    Not yet reported Celgene Corporation 36 participants Est. completion 2016-09 1 site Stand-alone
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT02821832

    Using Biomarkers to Predict TB Treatment Duration

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 946 participants Est. completion 2022-02-28 1 site Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT02832778

    Pharmacokinetics of Efavirenz in the Presence of Rifampicin and Isoniazid

    Not yet reported St Stephens Aids Trust 35 participants Est. completion 2018-02 2 sites Stand-alone
    Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT02836821

    Effect of Rifampicin on the Pharmacokinetics of Apatinib

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 20 participants Est. completion 2017-02 1 site Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT02846519

    Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Participants and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered Esketamine

    Not yet reported Janssen Research & Development, LLC 66 participants Est. completion 2016-05-28 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT02899702

    Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children

    Not yet reported Hospices Civils de Lyon Est. completion 2024-09 1 site Stand-alone
    Other conditions: Staphylococcal Infection, Streptococcal Infection
    View official trial listing →
  • Status unknown NCT NCT02901288

    Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis

    Not yet reported Beijing Chest Hospital 3900 participants Est. completion 2018-12 35 sites Stand-alone
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT02953847

    The Bioavailability of Rifampicin in (FDCs) Widely Used in South Africa to Treat Drug-susceptible (TB)

    Not yet reported University of Cape Town 21 participants Est. completion 2017-02 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT02957448

    A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects

    Not yet reported Bristol-Myers Squibb 16 participants Est. completion 2017-01 Stand-alone
    Other conditions: Atherothrombotic Diseases
    View official trial listing →
  • Completed NCT NCT02958709

    Optimizing Treatment to Improve TBM Outcomes in Children

    Not yet reported, Not yet reported Johns Hopkins University 38 participants Est. completion 2020-11-15 3 sites Stand-alone
    Other conditions: Tuberculosis, Meningeal
    View official trial listing →
  • Completed NCT NCT02959060

    A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects

    Not yet reported Bristol-Myers Squibb 16 participants Est. completion 2016-12 Stand-alone
    Other conditions: Thrombosis
    View official trial listing →
  • Completed NCT NCT02975440

    Drug-drug Interaction Study Between Orally Administered Rifampicin and Vilaprisan

    Not yet reported Bayer 12 participants Est. completion 2017-04-11 1 site Stand-alone
    Other conditions: Endometriosis
    View official trial listing →
  • Withdrawn NCT NCT02975570

    Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin

    Not yet reported Boston University Est. completion 2022-08 Stand-alone
    Other conditions: Tuberculosis Multi Drug Resistant Active
    View official trial listing →
  • Completed NCT NCT03002493

    To Assess the Effect of Rifampicin on the Pharmacokinetics of Eribulin Mesylate in Participants With Advanced Solid Tumors

    Not yet reported Eisai Limited 14 participants Est. completion 2011-06 2 sites Stand-alone
    Other conditions: Tumor
    View official trial listing →
  • Completed NCT NCT03012529

    Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics

    Not yet reported VA Office of Research and Development 843 participants Est. completion 2025-11-05 30 sites
    Other conditions: Osteomyelitis, Diabetes, Amputation
    View official trial listing →
  • Completed NCT NCT03048110

    Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or Induction

    Not yet reported Bayer 15 participants Est. completion 2017-07-19 1 site Stand-alone
    Other conditions: Biological Availability
    View official trial listing →
  • Completed NCT NCT03063580

    Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin

    Not yet reported Sanofi 16 participants Est. completion 2017-05-12 1 site Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03077607

    A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors

    Not yet reported Pfizer 36 participants Est. completion 2018-01-20 7 sites Stand-alone
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT03082183

    A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood

    Not yet reported Boehringer Ingelheim 16 participants Est. completion 2017-06-20 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT03173053

    S. Aureus Decolonization in HPN Patients.

    Not yet reported Radboud University Medical Center 63 participants Est. completion 2021-10-14 4 sites
    Other conditions: Staphylococcus Aureus, Motility Disorder
    View official trial listing →
  • Completed NCT NCT03174184

    Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB

    Not yet reported Johns Hopkins University 112 participants Est. completion 2022-05-13 1 site Stand-alone
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT03186482

    RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TP

    Not yet reported St. Stephens Clinical Research 21 participants Est. completion 2018-01-10 1 site
    Other conditions: HIV
    View official trial listing →
  • Status unknown NCT NCT03199690

    A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers

    Not yet reported St. Stephens Clinical Research 16 participants Est. completion 2018-03 Stand-alone
    Other conditions: HIV-1-infection, Tuberculosis
    View official trial listing →
  • Completed NCT NCT03213145

    Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers

    Not yet reported Enanta Pharmaceuticals, Inc 48 participants Est. completion 2017-09-07 1 site Stand-alone
    MASH
    View official trial listing →
  • Terminated NCT NCT03237182

    The Individualized M(X) Drug-resistant TB Treatment Strategy Study

    Not yet reported Centre for the AIDS Programme of Research in South Africa 205 participants Est. completion 2022-12-19 1 site Stand-alone
    Other conditions: Tuberculosis, Multidrug-Resistant
    View official trial listing →
  • Completed NCT NCT03267225

    Genetic Determinants of Clindamycin/Rifampin Interaction

    Dr Valerie ZELLER 84 participants Est. completion 2021-04-15 1 site
    Other conditions: VA Drug Interaction
    View official trial listing →
  • Completed NCT NCT03278483

    Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL)

    Not yet reported Instituto Nacional de Salud Publica, Mexico 396 participants Est. completion 2019-02-28 1 site
    Other conditions: Diabetes Mellitus, Tuberculin (Skin Test) Positive
    View official trial listing →
  • Status unknown NCT NCT03281226

    RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infection

    Not yet reported Fundação de Medicina Tropical Dr. Heitor Vieira Dourado 50 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Tuberculosis, Pulmonary, HIV/AIDS
    View official trial listing →
  • Completed NCT NCT03296800

    Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects

    Not yet reported Theracos 48 participants Est. completion 2017-12-06 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03301181

    Phase 1 Study to Investigate Effect of Rifampin and Itraconazole on the Pharmacokinetics of BGB-3111 in Healthy Subjects

    Not yet reported BeiGene 40 participants Est. completion 2017-11-13 1 site Stand-alone
    Other conditions: Healthy Volunteers: Asian, Non-Asian
    View official trial listing →
  • Completed NCT NCT03311841

    Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)

    Not yet reported Merck Sharp & Dohme LLC 32 participants Est. completion 2018-08-02 2 sites Stand-alone
    Other conditions: Renal Insufficiency
    View official trial listing →
  • Status unknown NCT NCT03326050

    Comparison Between Rifampicin and Gemifloxacin and Ciprofloxacin in Treatment of Rhinoscleroma

    Not yet reported Assiut University 60 participants Est. completion 2018-10 1 site
    Other conditions: Rhinoscleroma
    View official trial listing →
  • Terminated NCT NCT03334734

    Phase 2a Study of PBTZ169

    Not yet reported Nearmedic Plus LLC 16 participants Est. completion 2018-02-22
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT03338621

    Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

    Not yet reported, Not yet reported Global Alliance for TB Drug Development 455 participants Est. completion 2022-06-10 26 sites
    Other conditions: Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR, Tuberculosis, Drug-Resistant Tuberculosis
    View official trial listing →
  • Completed NCT NCT03340662

    Study Evaluating the Effects of Food, Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of CC-122

    Not yet reported Celgene 81 participants Est. completion 2018-01-27 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT03346837

    A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects

    Not yet reported Bristol-Myers Squibb 53 participants Est. completion 2017-12-20 1 site Stand-alone
    Other conditions: Malignancies Multiple
    View official trial listing →
  • Completed NCT NCT03353857

    Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam

    Not yet reported Bayer 68 participants Est. completion 2019-02-19 2 sites Stand-alone
    Other conditions: Biological Availability
    View official trial listing →
  • Status unknown NCT NCT03478033

    Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis

    Not yet reported Shanghai Public Health Clinical Center 230 participants Est. completion 2020-12-31 1 site
    Other conditions: Tuberculosis, Pulmonary, AIDS
    View official trial listing →
  • Completed NCT NCT03486314

    A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors

    Not yet reported Millennium Pharmaceuticals, Inc. 20 participants Est. completion 2021-02-28 4 sites Stand-alone
    Other conditions: Advanced Solid Neoplasm
    View official trial listing →
  • Completed NCT NCT03530995

    Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers

    Not yet reported Kadmon Corporation, LLC 73 participants Est. completion 2019-02-08 1 site Stand-alone
    Other conditions: Drug-drug Interaction, Autoimmune Diseases, Fibrotic Disease
    View official trial listing →
  • Completed NCT NCT03537495

    Pharmacokinetic Study of Linezolid for TB Meningitis

    Not yet reported Universitas Padjadjaran 36 participants Est. completion 2023-07-20 1 site Stand-alone
    Other conditions: Tuberculosis, Meningeal, Linezolid
    View official trial listing →
  • Completed NCT NCT03586726

    A Study to Investigate the Effect of Rifampicin on the PK of Multiple Doses of Balovaptin In Healthy Volunteers

    Not yet reported Hoffmann-La Roche 16 participants Est. completion 2018-11-15 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03596294

    A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan

    Not yet reported Idorsia Pharmaceuticals Ltd. 14 participants Est. completion 2018-08-03 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03622918

    Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii

    Not yet reported Gangnam Severance Hospital 9 participants Est. completion 2018-06-21 Stand-alone
    Other conditions: Colistin, Rifampin, Acinetobacter Infections
    View official trial listing →
  • Completed NCT NCT03637790

    Drug Interaction Study Evaluating the Effect of Rifampin on PK and Safety of PF 04965842.

    Not yet reported Pfizer 12 participants Est. completion 2018-12-14 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03709355

    Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs

    Not yet reported Viriom 56 participants Est. completion 2019-09-06 1 site Stand-alone
    Other conditions: HIV-1-infection
    View official trial listing →
  • Completed NCT NCT03712540

    An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants

    Not yet reported Bristol-Myers Squibb 39 participants Est. completion 2018-11-08 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT03712709

    Clinical Evaluation of the Truenat Point-of-care Tuberculosis Diagnostic Test

    Foundation for Innovative New Diagnostics, Switzerland 1926 participants Est. completion 2020-07-09 4 sites
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT03723395

    A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib

    Not yet reported Seagen Inc. 116 participants Est. completion 2018-12-28 2 sites Stand-alone
    Other conditions: Drug-drug Interaction
    View official trial listing →
  • Completed NCT NCT03731559

    Efficacy, Safety and Pharmacokinetics of DTG With RIF

    Not yet reported The HIV Netherlands Australia Thailand Research Collaboration 123 participants Est. completion 2025-06-30 10 sites
    Other conditions: HIV/TB Coinfection
    View official trial listing →
  • Completed NCT NCT03750721

    Staphylococcal Acute Post-Operative PJI Treated With 'DAIR' And Impact Of Rifampin

    Hospices Civils de Lyon 79 participants Est. completion 2018-05-01 1 site
    Other conditions: Bone and Joint Infection, Antibiotic Resistant Staphylococcus Aureus Infection
    View official trial listing →
  • Completed NCT NCT03755778

    Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

    Not yet reported Enanta Pharmaceuticals, Inc 72 participants Est. completion 2019-01-27 1 site Stand-alone
    Other conditions: RSV Infection
    View official trial listing →
  • Completed NCT NCT03758469

    A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules

    Not yet reported Sichuan Haisco Pharmaceutical Group Co., Ltd 16 participants Est. completion 2019-03-10 1 site Stand-alone
    Other conditions: Anesthesia, Sedation
    View official trial listing →
  • Completed NCT NCT03798600

    Pharmacokinetics/Pharmacodynamics (PK/PD) of Caspofungin in Intensive Care Unit (ICU) Patients. An Open Observational Study for Antifungal Treatment's Optimization

    Careggi Hospital 20 participants Est. completion 2018-12-31
    Other conditions: Critical Illness, Infection
    View official trial listing →
  • Completed NCT NCT03800381

    Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet

    University of Florida 92 participants Est. completion 2024-08-31 1 site
    Other conditions: Tuberculosis, Human Immunodeficiency Virus, Coinfection
    View official trial listing →
  • Completed NCT NCT03814200

    A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects

    Not yet reported Viatris Innovation GmbH 14 participants Est. completion 2019-02-19 1 site Stand-alone
    Other conditions: Healthy Subject
    View official trial listing →
  • Completed NCT NCT03819114

    Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 122 participants Est. completion 2020-11-30 18 sites
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT03832023

    Community-based Tuberculosis Tracing and Preventive Therapy

    Not yet reported Elizabeth Glaser Pediatric AIDS Foundation 1400 participants Est. completion 2022-08-01 25 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT03851588

    Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis

    Not yet reported University of Cape Town 108 participants Est. completion 2022-06-28 1 site
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Withdrawn NCT NCT03862248

    Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More

    Not yet reported Institute of Tropical Medicine, Belgium Est. completion 2022-10-01 1 site Stand-alone
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT03882177

    StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 16 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Tuberculosis, Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT03915366

    Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia

    Not yet reported, Not yet reported Hospital Universitario 12 de Octubre 563 participants Est. completion 2025-01-31 13 sites Stand-alone
    Other conditions: Pneumonia, HIV/AIDS, Tuberculosis, Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT03927313

    Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM

    Not yet reported University of Cape Town 52 participants Est. completion 2021-03-31 4 sites Stand-alone
    Other conditions: Tuberculosis Meningitis, HIV-1-infection
    View official trial listing →
  • Completed NCT NCT03928327

    A Study to Evaluate Drug-Drug Interaction of TAK-788 With Itraconazole and Rifampin in Healthy Adult Participants

    Not yet reported Millennium Pharmaceuticals, Inc. 24 participants Est. completion 2019-08-16 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03983239

    Effect of Rifampin and Efavirenz on the Pharmacokinetics of Fedratinib in Healthy Adult Subjects

    Not yet reported Celgene 32 participants Est. completion 2019-11-06 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03988933

    2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 1368 participants Est. completion 2024-12-31 9 sites Stand-alone
    Other conditions: Latent Tuberculosis
    View official trial listing →
  • Completed NCT NCT03991312

    Study to Evaluate the Effect of Multiple Doses of Itraconazole and Rifampin on the Single-Dose Pharmacokinetics of Mitapivat Sulfate (AG-348) in Healthy Adult Participants

    Not yet reported Agios Pharmaceuticals, Inc. 28 participants Est. completion 2019-09-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04006353

    The Drug Interaction Between Albuvirtide (ABT) and Rifampin（RIF） in Healthy Adult Subjects

    Not yet reported Shanghai Public Health Clinical Center 24 participants Est. completion 2019-12-03 1 site Stand-alone
    Other conditions: Drug Interaction
    View official trial listing →
  • Completed NCT NCT04011124

    A Drug-drug Interaction Trial of Rifampicin Pharmacokinetics Effect on Fluzoparib

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 16 participants Est. completion 2019-09-16 1 site Stand-alone
    Other conditions: Healthy Male Subjects
    View official trial listing →
  • Completed NCT NCT04021121

    Adjunctive Linezolid for the Treatment of Tuberculous Meningitis

    Not yet reported University of California, San Francisco 40 participants Est. completion 2023-12-04 1 site
    Other conditions: Tuberculosis, Meningeal
    View official trial listing →
  • Completed NCT NCT04029584

    Drug-Drug Interaction Between Rifampin and Fluvastatin

    Not yet reported University of California, San Francisco 10 participants Est. completion 2020-04-25 1 site Stand-alone
    Other conditions: Drug-drug Interaction
    View official trial listing →
  • Completed NCT NCT04050449

    Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD

    Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 1339 participants Est. completion 2023-03-31 14 sites
    Other conditions: HIV-1-infection
    View official trial listing →
  • Completed NCT NCT04060719

    A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 894416 in the Blood

    Not yet reported Boehringer Ingelheim 16 participants Est. completion 2019-10-17 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04062201

    Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

    Not yet reported Wits Health Consortium (Pty) Ltd 402 participants Est. completion 2024-04-15 2 sites
    Other conditions: Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis, Multi Drug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis
    View official trial listing →
  • Completed NCT NCT04070495

    A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin

    Not yet reported Kyowa Kirin Co., Ltd. 20 participants Est. completion 2019-11-19 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT04080609

    DDI Study Between Dorzagliatin and Rifampicin

    Not yet reported Hua Medicine Limited 15 participants Est. completion 2018-04-17 1 site Stand-alone
    Other conditions: Drug Interaction
    View official trial listing →
  • Completed NCT NCT04118842

    A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin

    Not yet reported AstraZeneca 40 participants Est. completion 2020-02-26 1 site Stand-alone
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT04121078

    A Study to Evaluate the Effect of Single-Dose Intravenous Rifampin as a Prototypic Inhibitor of Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 on the Single-Dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants

    Not yet reported Millennium Pharmaceuticals, Inc. 12 participants Est. completion 2019-11-16 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04121195

    Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load

    Not yet reported, Not yet reported University of Liverpool 26 participants Est. completion 2023-05-20 1 site
    Other conditions: HIV/AIDS, Tuberculosis
    View official trial listing →
  • Completed NCT NCT04147676

    Evaluation of Centralised TB Assay Solutions

    Foundation for Innovative New Diagnostics, Switzerland 1050 participants Est. completion 2023-09-01 6 sites
    Other conditions: Tuberculosis, Drug-resistant Tuberculosis
    View official trial listing →
  • Completed NCT NCT04166474

    Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin

    Not yet reported Helen Reynolds 36 participants Est. completion 2024-02-07 2 sites Stand-alone
    Other conditions: Hiv, Tuberculosis
    View official trial listing →
  • Completed NCT NCT04166669

    A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001

    Not yet reported Basilea Pharmaceutica 36 participants Est. completion 2020-03-03 2 sites Stand-alone
    Other conditions: Fungal Infection
    View official trial listing →
  • Completed NCT NCT04176250

    Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis

    Not yet reported Gates Medical Research Institute 93 participants Est. completion 2022-10-05 4 sites
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT04187469

    Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB

    Not yet reported Fifth Affiliated Hospital, Sun Yat-Sen University 286 participants Est. completion 2024-02-01 1 site Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT04208789

    Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis

    Hasanuddin University 524 participants Est. completion 2020-10-02 5 sites
    Other conditions: MDR Tuberculosis, Resistance to Tuberculostatic Drugs
    View official trial listing →
  • Completed NCT NCT04266509

    Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600

    Not yet reported Pfizer 12 participants Est. completion 2020-09-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04268394

    A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677

    Not yet reported Celgene 48 participants Est. completion 2021-06-02 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT04290390

    Annovera™ Drug-Drug Interaction Study

    Not yet reported TherapeuticsMD 67 participants Est. completion 2021-01-06 1 site
    Other conditions: Women, Contraception
    View official trial listing →
  • Withdrawn NCT NCT04301310

    Study to Evaluate the Effect of Rifampin on the Drug Levels in Blood and Safety of BMS-986235 in Healthy Participants

    Not yet reported Bristol-Myers Squibb Est. completion 2020-03-16 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Terminated NCT NCT04311502

    Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 104 participants Est. completion 2025-06-24 6 sites
    Other conditions: HIV, Tuberculosis
    View official trial listing →
  • Completed NCT NCT04325438

    The Impact of Pharmacists' Interventions on the Quality of Life of HIV-TB Co-infection Outpatients in Indonesia

    Not yet reported Bekasi City Public Hospital 25 participants Est. completion 2019-03-30 3 sites Stand-alone
    Other conditions: Pharmaceutical Care, HIV/AIDS, Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT04349579

    Evaluation of the Effects of Irrigation of the Extraction Socket With Rifamycine

    Not yet reported Yuzuncu Yil University 35 participants Est. completion 2023-12-15 1 site
    Other conditions: Impacted Third Molar Tooth
    View official trial listing →
  • Completed NCT NCT04424264

    The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coadministered With Tenofovir Alafenamide Fumarate During the Maintenance Phase of Tuberculosis Treatment in TB/HIV-1 Coinfected Participants

    Not yet reported Professor Francois Venter 18 participants Est. completion 2020-10-30 2 sites Stand-alone
    Other conditions: HIV-1-infection, Tuberculosis
    View official trial listing →
  • Completed NCT NCT04437836

    Evaluation of Pharmacokinetics and Safety Tolerability of Higher Doses of Rifampic

    Not yet reported, Not yet reported Kilimanjaro Clinical Research Institute 31 participants Est. completion 2023-12-31 4 sites Stand-alone
    Other conditions: Clinical Trial
    View official trial listing →
  • Completed NCT NCT04439578

    Effect of Rifampicin on the Pharmacokinetics of SHR6390 in Healthy Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 18 participants Est. completion 2021-01-15 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT04440631

    Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection

    AO Research Institute Davos 12 participants Est. completion 2022-12-31 2 sites
    Other conditions: Fractures, Bone, Infection, Bacterial, Joint Infection, Bone Infection
    View official trial listing →
  • Completed NCT NCT04463680

    Rifampin and the Contraceptive Implant

    Not yet reported University of Colorado, Denver 24 participants Est. completion 2022-02-22 1 site Stand-alone
    Other conditions: Contraception, Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT04485156

    Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)

    Not yet reported Seoul National University Hospital 926 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Status unknown NCT NCT04488458

    Susceptibility Testing of Biofilm to Guide Treatment of Periprosthetic Joint Infections

    Not yet reported Vastra Gotaland Region 40 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Prosthetic Joint Infection, Prosthetic Infection, Hip Prosthesis Infection, Knee Prosthesis Infection
    View official trial listing →
  • Status unknown NCT NCT04504851

    Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct

    Not yet reported National University Hospital, Singapore 154 participants Est. completion 2021-03-31 6 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT04510649

    Surufatinib DDI With a PPI and a CYP3A Inducer

    Not yet reported Hutchison Medipharma Limited 28 participants Est. completion 2021-03-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT04518228

    Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

    National Institute of Allergy and Infectious Diseases (NIAID) 205 participants Est. completion 2025-07-10 23 sites
    Other conditions: HIV, Tuberculosis
    View official trial listing →
  • Completed NCT NCT04525235

    Phenotyping of High Dose Rifampicin

    Not yet reported Radboud University Medical Center 25 participants Est. completion 2021-08-12 2 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT04532918

    Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers

    Not yet reported AstraZeneca 14 participants Est. completion 2020-11-23 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Terminated NCT NCT04553406

    Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease

    Not yet reported Spero Therapeutics 2 participants Est. completion 2021-01-28 9 sites
    Other conditions: Mycobacterium Avium Complex, Non-tuberculous Mycobacterium Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT04557397

    Fruquintinib CYP3A Inhibitor and Inducer Study

    Not yet reported Hutchison Medipharma Limited 28 participants Est. completion 2020-10-18 1 site
    Other conditions: Drug Drug Interaction
    View official trial listing →
  • Withdrawn NCT NCT04558216

    Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants

    Not yet reported Phathom Pharmaceuticals, Inc. Est. completion 2021-02-19 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT04565574

    A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabeprazole or Rifampin in Healthy Participants

    Not yet reported Eisai Co., Ltd. 42 participants Est. completion 2021-03-31 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT04584515

    IMP4297 DDI (Drug-Drug Interaction)Trial in Healthy Male Volunteers

    Not yet reported Impact Therapeutics, Inc. 32 participants Est. completion 2021-05-27 1 site Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Completed NCT NCT04606537

    Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects

    Not yet reported KBP Biosciences 24 participants Est. completion 2020-11-30 1 site Stand-alone
    Other conditions: Healthy, Drug Drug Interaction
    View official trial listing →
  • Completed NCT NCT04649723

    Drug-Drug Interaction of SHR1459 With a Strong CYP3A Index Inducer (Rifampicin)

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 20 participants Est. completion 2020-12-14 1 site Stand-alone
    Other conditions: Healthy Subjects, Drug-drug Interaction, Pharmacokinetics, SHR1459
    View official trial listing →
  • Completed NCT NCT04721795

    Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)

    Not yet reported, Not yet reported Obafemi Awolowo University Teaching Hospital 150 participants Est. completion 2022-06-30 2 sites Stand-alone
    Other conditions: Tuberculosis, Pulmonary, Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT04746547

    Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB

    Not yet reported University of KwaZulu 20 participants Est. completion 2025-07-31 1 site
    Other conditions: Tuberculosis, Hiv
    View official trial listing →
  • Status unknown NCT NCT04808648

    The Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SH-1028

    Not yet reported Nanjing Sanhome Pharmaceutical, Co., Ltd. 40 participants Est. completion 2021-06-30 1 site Stand-alone
    Other conditions: Healthy Male Volunteers
    View official trial listing →
  • Completed NCT NCT04830462

    Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation

    Not yet reported Herlev and Gentofte Hospital 32 participants Est. completion 2023-05-01 1 site
    Type 2 diabetes Other conditions: Latent Tuberculosis
    View official trial listing →
  • Completed NCT NCT04843449

    Study to Evaluate the Effects of Itraconazole and Rifampin on the Pharmacokinetics of ASC40 in Healthy Subjects

    Not yet reported Ascletis Pharmaceuticals Co., Ltd. 24 participants Est. completion 2021-05-14 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04914936

    A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196

    Not yet reported Acerta Pharma BV 72 participants Est. completion 2014-10-16 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT04916899

    Safety of doTBal® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance Program

    Laboratorios Silanes S.A. de C.V. 47 participants Est. completion 2016-09 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT04933682

    Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult Participants

    Not yet reported Alexion Pharmaceuticals, Inc. 16 participants Est. completion 2021-08-23 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04946500

    Clindamycin in Prosthetic Joint Infections Caused by Staphylococcus (CISTA)

    University Hospital, Brest 120 participants Est. completion 2021-10-15 1 site
    Other conditions: Prosthetic Joint Infection, Staphylococcus
    View official trial listing →
  • Status unknown NCT NCT04951713

    Effect of Clarithromycin and Rifampicin on the Pharmacokinetics of XZP-3287 in Healthy Subjects

    Not yet reported Xuanzhu Biopharmaceutical Co., Ltd. 60 participants Est. completion 2021-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT04959266

    A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib

    Not yet reported AstraZeneca 5 participants Est. completion 2022-06-01 5 sites Stand-alone
    Other conditions: Advanced Solid Tumours
    View official trial listing →
  • Completed NCT NCT04972903

    Impact of Malnutrition on Pharmacokinetic of Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children (TB-Speed TB-PK)

    Institut National de la Santé Et de la Recherche Médicale, France 85 participants Est. completion 2023-03-22 4 sites
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT05005637

    The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis with Positive IGRA

    Not yet reported Fakultas Kedokteran Universitas Indonesia 78 participants Est. completion 2024-11-20 1 site Stand-alone
    Other conditions: Tuberculous Uveitis
    View official trial listing →
  • Status unknown NCT NCT05021731

    Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease

    Not yet reported Miguel Santín 225 participants Est. completion 2025-04-30 Stand-alone
    Other conditions: Latent Tuberculosis, Kidney Failure
    View official trial listing →
  • Active, not recruiting NCT NCT05046860

    Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements

    Not yet reported Centre Hospitalier Universitaire de Nice 43 participants Est. completion 2026-08-30 4 sites Stand-alone
    Other conditions: Osteoarticular Infection
    View official trial listing →
  • Completed NCT NCT05047055

    Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients

    Tuberculosis Research Centre, India 550 participants Est. completion 2026-04-17 1 site
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT05057949

    A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants

    Not yet reported Sunshine Lake Pharma Co., Ltd. 32 participants Est. completion 2023-09-28 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT05069870

    A Study to Investigate the Drug-drug Interactions (DDIs) of SKLB1028 With Itraconazole, Gemfibrozil or Rifampicin in Healthy Subjects

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 42 participants Est. completion 2021-11 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Active, not recruiting NCT NCT05073926

    Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis

    Region Skane 100 participants Est. completion 2026-12 1 site
    Other conditions: Latent Tuberculosis, Staphylococcus Aureus
    View official trial listing →
  • Withdrawn NCT NCT05074147

    Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2)

    Not yet reported Tourcoing Hospital Est. completion 2026-11 18 sites Stand-alone
    Other conditions: Osteomyelitis - Foot
    View official trial listing →
  • Completed NCT NCT05098041

    A Study of Soticlestat and Rifampin in Healthy Adults

    Not yet reported Takeda 15 participants Est. completion 2022-03-03 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Active, not recruiting NCT NCT05118490

    Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients

    Not yet reported The Aurum Institute NPC 1000 participants Est. completion 2025-12-31 4 sites Stand-alone
    Other conditions: HIV Seropositivity, Tuberculosis, Household Contact
    View official trial listing →
  • Status unknown NCT NCT05124678

    Pharmacogenetics-guided Isoniazid Dosing in TB-HIV

    Not yet reported Makerere University 40 participants Est. completion 2022-06-30 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT05134337

    Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants

    Not yet reported Loxo Oncology, Inc. 27 participants Est. completion 2020-10-30 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Terminated NCT NCT05156437

    Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)

    Not yet reported West Virginia University 5 participants Est. completion 2024-10-31 1 site Stand-alone
    Other conditions: Endocarditis
    View official trial listing →
  • Status unknown NCT NCT05169554

    Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy

    Not yet reported Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID) 140 participants Est. completion 2026-05-31 3 sites Stand-alone
    Other conditions: Buruli Ulcer
    View official trial listing →
  • Status unknown NCT NCT05215990

    Efficacy of Metformin for Sputum Conversion in Patients With Active Pulmonary Tuberculosis

    Not yet reported, Not yet reported Mahidol University 80 participants Est. completion 2023-03-31 1 site
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT05221502

    Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 122 participants Est. completion 2024-05-19 6 sites
    Other conditions: Pulmonary TB
    View official trial listing →
  • Completed NCT NCT05255276

    PK Study to Assess Drug-drug Interaction Between Sitravatinib and a P-gp Inducer and an Inhibitor.

    Not yet reported Mirati Therapeutics Inc. 36 participants Est. completion 2023-02-10 1 site
    Other conditions: Healthy Adults
    View official trial listing →
  • Completed NCT NCT05316857

    DDI Study of Orelabrutinib

    Not yet reported Beijing InnoCare Pharma Tech Co., Ltd. 36 participants Est. completion 2022-06-13 1 site
    Other conditions: Healthy Person
    View official trial listing →
  • Completed NCT NCT05338489

    A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy Participants

    Not yet reported Eli Lilly and Company 24 participants Est. completion 2018-08-22 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05357820

    A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK

    Not yet reported Nuvation Bio Inc. 56 participants Est. completion 2021-12-03 1 site Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Completed NCT NCT05359055

    Drug-drug Interaction Study of SPH3127

    Not yet reported, Not yet reported Shanghai Pharmaceuticals Holding Co., Ltd 40 participants Est. completion 2022-01-21 1 site Stand-alone
    Other conditions: Drug Drug Interaction
    View official trial listing →
  • Completed NCT NCT05388448

    EBA, Safety and Tolerability of Sanfetrinem Cilexetil

    Not yet reported TASK Applied Science 54 participants Est. completion 2024-08-19 1 site Stand-alone
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT05389722

    A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the Drug Levels of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy Participants

    Not yet reported Bristol-Myers Squibb 24 participants Est. completion 2022-11-12 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05406453

    Whole Genome Sequencing of Tuberculosis for Disease Control in Madagascar

    Not yet reported Institut Pasteur de Madagascar 98362 participants Est. completion 2024-06-30 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT05406479

    Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)

    Not yet reported Institute of Tropical Medicine, Belgium 313 participants Est. completion 2023-01-26 1 site Stand-alone
    Other conditions: Leprosy
    View official trial listing →
  • Status unknown NCT NCT05431673

    Efficacy Of Doxycycline & Versus Rifampin In Treatment Of Rhinoscleroma

    Not yet reported Assiut University 45 participants Est. completion 2023-07-31
    Other conditions: Rhinoscleroma
    View official trial listing →
  • Status unknown NCT NCT05443178

    Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy

    Not yet reported University of Zurich 16 participants Est. completion 2025-06-01 1 site
    Other conditions: Tuberculosis Infection
    View official trial listing →
  • Status unknown NCT NCT05454345

    Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment

    Not yet reported First Affiliated Hospital of Zhejiang University 620 participants Est. completion 2026-06-30 Stand-alone
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT05473195

    A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098

    Not yet reported TASK Applied Science 105 participants Est. completion 2024-04-16 1 site
    Other conditions: Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
    View official trial listing →
  • Completed NCT NCT05497674

    Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects

    Not yet reported Sunshine Lake Pharma Co., Ltd. 28 participants Est. completion 2023-02-24 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05555303

    Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis

    Not yet reported Rwanda Biomedical Centre 20 participants Est. completion 2026-02 1 site
    Other conditions: Tuberculosis, Multidrug-Resistant
    View official trial listing →
  • Active, not recruiting NCT NCT05556746

    Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible Tuberculosis

    Not yet reported Brigham and Women's Hospital 94 participants Est. completion 2027-01 2 sites
    Other conditions: Tuberculosis, Pulmonary, HIV
    View official trial listing →
  • Completed NCT NCT05575297

    A Drug-drug Interaction Study to Evaluate the Effect of Rifampicin and Febuxostat on the Pharmacokinetics of Methotrexate in Healthy Subjects

    Not yet reported Seoul National University Hospital 12 participants Est. completion 2022-05-09 1 site Stand-alone
    Other conditions: Drug Interaction
    View official trial listing →
  • Status unknown NCT NCT05575518

    A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis

    Not yet reported Stellah Mpagama 414 participants Est. completion 2026-03-31 1 site Stand-alone
    Other conditions: Tuberculosis, Human Immunodeficiency Virus
    View official trial listing →
  • Completed NCT NCT05577624

    A Study to Evaluate the Drug-drug Interaction Effect of Rifampin on the Pharmacokinetics of AMG 510 in Healthy Participants

    Not yet reported Amgen 14 participants Est. completion 2019-12-01 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT05586230

    Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 32 participants Est. completion 2026-04-28 5 sites
    Other conditions: Tuberculosis, Rifampicin Resistant Tuberculosis
    View official trial listing →
  • Completed NCT NCT05592223

    Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines

    Not yet reported Fred Hutchinson Cancer Center 20 participants Est. completion 2023-12-01 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT05602597

    HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI

    Not yet reported Hutchmed 59 participants Est. completion 2022-08-06 1 site Stand-alone
    Other conditions: Relapsed or Refractory Lymphoma
    View official trial listing →
  • Completed NCT NCT05621343

    New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis

    Region Skane 89 participants Est. completion 2025-12-01 1 site
    Other conditions: Latent Tuberculosis, Persistent Infection, Mycobacterium Tuberculosis
    View official trial listing →
  • Completed NCT NCT05631678

    Drug-drug Interaction Study Beteewn ASK120067 and Rifampicin or Itraconazole

    Not yet reported Jiangsu Aosaikang Pharmaceutical Co., Ltd. 48 participants Est. completion 2022-08-03 1 site Stand-alone
    Other conditions: Locally Advanced or Metastatic NSCLC
    View official trial listing →
  • Completed NCT NCT05635110

    Evaluation of the Effects of Omeprazole and Rifampin on the Pharmacokinetics of VX-548 in Healthy Participants

    Not yet reported Vertex Pharmaceuticals Incorporated 31 participants Est. completion 2023-06-08 1 site Stand-alone
    Other conditions: Pain
    View official trial listing →
  • Status unknown NCT NCT05664568

    The BLAST- 1 Trial - Cephalexin+Amoxicillin-clavulanate for Tuberculosis

    Not yet reported Western Sydney Local Health District 30 participants Est. completion 2024-12 3 sites
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Active, not recruiting NCT NCT05766267

    Short-course Regimens for the Treatment of Pulmonary Tuberculosis

    Not yet reported, Not yet reported Centers for Disease Control and Prevention 288 participants Est. completion 2027-12-31 8 sites
    Other conditions: Tuberculosis, Pulmonary, Tuberculosis Infection
    View official trial listing →
  • Completed NCT NCT05826574

    A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants

    Not yet reported Insmed Incorporated 32 participants Est. completion 2023-07-16 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Active, not recruiting NCT NCT05840809

    Pharmacokinetics of Drugs Used to Treat Drug Sensitive Tuberculosis in Breastfeeding Mother-infant Pairs

    University of Liverpool 20 participants Est. completion 2026-12-06 1 site
    Other conditions: Tuberculosis Active, Breastfeeding, Tuberculosis
    View official trial listing →
  • Terminated NCT NCT05861258

    Pharmacokinetic Study of Minocycline in Patients With Pulmonary Nontuberculous Mycobacterial Disease

    Not yet reported Radboud University Medical Center 12 participants Est. completion 2025-06-11 1 site
    Other conditions: Mycobacterium Avium Complex Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT05894954

    Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment

    Not yet reported Alzheimer's Prevention and Reversal Project, Inc. 73 participants Est. completion 2026-02-09 6 sites Stand-alone
    Other conditions: Mild Cognitive Impairment, Dementia, Mild
    View official trial listing →
  • Completed NCT NCT05896930

    Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis

    Not yet reported TASK Applied Science 134 participants Est. completion 2021-01-04 1 site Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT05899829

    Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of Camlipixant

    Not yet reported Bellus Health Inc. - a GSK company 42 participants Est. completion 2023-08-08 1 site Stand-alone
    Other conditions: Cough, Healthy
    View official trial listing →
  • Completed NCT NCT05902728

    Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects

    Not yet reported Shanghai Henlius Biotech 20 participants Est. completion 2023-12-19 1 site Stand-alone
    Other conditions: NSCLC
    View official trial listing →
  • Terminated NCT NCT05977868

    Comparing Oral Versus Parenteral Antimicrobial Therapy

    Not yet reported West Virginia University 94 participants Est. completion 2025-02-14 1 site
    Other conditions: Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection, Pulmonary Infection, Gastrointestinal Infection, Genitourinary Infection
    View official trial listing →
  • Completed NCT NCT05991401

    Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy Adults

    Not yet reported Dong-A ST Co., Ltd. 18 participants Est. completion 2023-11-17 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05994742

    An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM

    Not yet reported Queen Mary University of London 674 participants Est. completion 2026-07-30 9 sites Stand-alone
    Other conditions: Severe Acute Malnutrition, HIV, Comorbidities and Coexisting Conditions, Child Malnutrition
    View official trial listing →
  • Completed NCT NCT06004947

    A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications

    Not yet reported Amgen 32 participants Est. completion 2016-06-10 1 site Stand-alone
    Other conditions: Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
    View official trial listing →
  • Completed NCT NCT06024915

    A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 40 participants Est. completion 2024-05-06 1 site Stand-alone
    Other conditions: Myelofibrosis
    View official trial listing →
  • Completed NCT NCT06031454

    Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin

    Not yet reported Guangdong Raynovent Biotech Co., Ltd 56 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Drug Drug Interaction
    View official trial listing →
  • Terminated NCT NCT06041919

    Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis

    Not yet reported Thirty Respiratory Limited 20 participants Est. completion 2025-03-06 1 site Stand-alone
    Other conditions: Rifampicin Susceptible Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT06064539

    Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects

    Not yet reported Sanofi 30 participants Est. completion 2020-07-08 1 site Stand-alone
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Active, not recruiting NCT NCT06081361

    Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort

    Not yet reported Beijing Chest Hospital 186 participants Est. completion 2026-12-31 39 sites
    Other conditions: Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT06165822

    A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 40 participants Est. completion 2024-03 1 site Stand-alone
    Other conditions: Advanced Malignant Neoplasm
    View official trial listing →
  • Withdrawn NCT NCT06191692

    1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam

    Not yet reported Freundeskreis Für Internationale Tuberkulosehilfe e.V Est. completion 2025-12-30 2 sites
    Other conditions: Tuberculosis Infection
    View official trial listing →
  • Completed NCT NCT06194864

    Drug Interaction Study

    Not yet reported Emalex Biosciences Inc. 45 participants Est. completion 2024-05-22 1 site Stand-alone
    Other conditions: Drug Interaction
    View official trial listing →
  • Not yet recruiting NCT NCT06205589

    Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 1500 participants Est. completion 2029-10-13
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT06246695

    A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Jaktinib in Healthy Volunteers

    Not yet reported Suzhou Zelgen Biopharmaceuticals Co.,Ltd 40 participants Est. completion 2022-01-12 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06255951

    Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects

    Not yet reported TYK Medicines, Inc 48 participants Est. completion 2024-12-27 1 site Stand-alone
    Other conditions: NSCLC
    View official trial listing →
  • Status unknown NCT NCT06332053

    A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SY-5007 in Healthy Subjects

    Not yet reported Shouyao Holdings (Beijing) Co. LTD 28 participants Est. completion 2024-06-01 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT06344936

    Drug-drug Interaction Study of HRS-1780 Tablets in Healthy Subjects

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 28 participants Est. completion 2024-07 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT06348290

    Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

    Not yet reported Jemincare 72 participants Est. completion 2024-09-15 Stand-alone
    Other conditions: Solid Tumor, Adult
    View official trial listing →
  • Completed NCT NCT06363630

    A Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibitor (Itraconazole) and Inducer (Rifampin) on the Drug Levels of Golcadomide (BMS-986369) in Healthy Participants

    Not yet reported Celgene 35 participants Est. completion 2024-08-29 2 sites Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT06392594

    Performance of Xpert MTB/RIF and XDR Assay for Diagnosis of Pulmonary Tuberculosis and Resistant Pulmonary TB

    Assiut University 46 participants Est. completion 2025-05-23
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Status unknown NCT NCT06476210

    The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)

    Not yet reported Beijing Chest Hospital 45 participants Est. completion 2026-06 7 sites
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Active, not recruiting NCT NCT06489431

    Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement

    Not yet reported Rush University Medical Center 200 participants Est. completion 2027-12-31 3 sites
    Other conditions: Erectile Dysfunction, Penile Prosthesis; Complications, Infection or Inflammation
    View official trial listing →
  • Not yet recruiting NCT NCT06526039

    A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB

    Not yet reported Taipei Medical University WanFang Hospital 100 participants Est. completion 2029-12
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Status unknown NCT NCT06539455

    Analysis of Liver Injury Risk Factors in a Multiethnic Population Treated With Antituberculosis Drugs

    Stefania Cheli 127 participants Est. completion 2024-09-30 1 site
    Other conditions: Tuberculosis Infection
    View official trial listing →
  • Status unknown NCT NCT06562088

    A Drug-Drug Interaction (DDI) Study of HDM1002 With Rifampicin and Itraconazole in Healthy Subjects

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 40 participants Est. completion 2024-12-30 1 site Stand-alone
    Other conditions: Healthy Adult Subject
    View official trial listing →
  • Not yet recruiting NCT NCT06658964

    Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects

    Not yet reported Jemincare 48 participants Est. completion 2025-03-21 Stand-alone
    Other conditions: ADPKD (autosomal Dominant Polycystic Kidney Disease)
    View official trial listing →
  • Status unknown NCT NCT06662773

    Drug-Drug Interaction (DDI) Study for TQB3616

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 40 participants Est. completion 2025-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Not yet recruiting NCT NCT06701136

    Drug-Drug Interaction and Food Effect of Sudapyridine(WX-081) With Itraconazole and Rifampin in Healthy Chinese Adults

    Not yet reported Shanghai Jiatan Pharmatech Co., Ltd 16 participants Est. completion 2026-02-12 Stand-alone
    Other conditions: Rifampicin-Resistant Pulmonary Tuberculosis Patients
    View official trial listing →
  • Completed NCT NCT06794502

    Butterfly Pea Flower (Clitoria Ternatea) for Adjuvant TB Treatment

    Not yet reported Universitas Muhammadiyah Semarang 28 participants Est. completion 2024-08-31 2 sites
    Other conditions: Tuberculosis (TB), Tuberculosis Treatment Effectiveness
    View official trial listing →
  • Completed NCT NCT06811792

    Intrathecal Therapy for Adult Tuberculous Meningitis: Impact on Clinical Outcomes

    Beijing Chest Hospital 837 participants Est. completion 2024-12-31
    Other conditions: Tuberculous Meningitis
    View official trial listing →
  • Completed NCT NCT06822166

    Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride

    Not yet reported Ahon Pharmaceutical Co., Ltd. 68 participants Est. completion 2024-01-23 1 site Stand-alone
    Other conditions: Interaction Drug Food
    View official trial listing →
  • Not yet recruiting NCT NCT06917495

    Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis

    Not yet reported Shandong University 300 participants Est. completion 2029-12-31 1 site
    Other conditions: Mild Spinal Tuberculosis
    View official trial listing →
  • Completed NCT NCT07002255

    A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Rifampicin Capsules (RIF)

    Not yet reported Henan Genuine Biotech Co., Ltd. 15 participants Est. completion 2023-10-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT07018635

    A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants

    Not yet reported Incyte Corporation 63 participants Est. completion 2025-09-29 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT07056842

    This is an Open-label, Non-randomized Study to Assess the Pharmacokinetics (PK) of VCT220 in Healthy Volunteers When Administered With Rifampin or Itraconazole

    Not yet reported Vincentage Pharma Co., Ltd 32 participants Est. completion 2025-09-30 1 site Stand-alone
    Other conditions: Obesity &Amp; Overweight
    View official trial listing →
  • Not yet recruiting NCT NCT07069582

    Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 60 participants Est. completion 2026-10-31 1 site Stand-alone
    Other conditions: Tuberculosis Infection, Healthy Volunteer, Breastfeeding
    View official trial listing →
  • Not yet recruiting NCT NCT07118696

    Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease

    Not yet reported Hamilton Health Sciences Corporation 1000 participants Est. completion 2030-01-31 Stand-alone
    Other conditions: Pulmonary TB
    View official trial listing →
  • Not yet recruiting NCT NCT07129629

    Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

    Not yet reported Shanghai Pulmonary Hospital, Shanghai, China 45 participants Est. completion 2027-12-31
    Other conditions: Tuberculosis, Pulmonary, Drug-Susceptible Pulmonary Tuberculosis
    View official trial listing →
  • Active, not recruiting NCT NCT07134478

    Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects

    Not yet reported Haisco Pharmaceutical Group Co., Ltd. 24 participants Est. completion 2026-06-01 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Enrolling by invitation NCT NCT07148960

    Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes?

    Not yet reported West Virginia University 300 participants Est. completion 2027-07 1 site Stand-alone
    Other conditions: Staphylococcus Aureus Bacteremia
    View official trial listing →
  • Completed NCT NCT07155408

    Topical Rifamycin SV for Wound Healing After Sapphire FUE Hair Transplantation

    Not yet reported Elif Asena KANTARCI 70 participants Est. completion 2022-06-22 1 site
    Other conditions: Androgenetic Alopecia, Wound Healing
    View official trial listing →
  • Not yet recruiting NCT NCT07163143

    Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

    Not yet reported University College, London 784 participants Est. completion 2029-04 4 sites Stand-alone
    Other conditions: Tuberculosis (TB)
    View official trial listing →
  • Not yet recruiting NCT NCT07191834

    A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis

    Wuhan Pulmonary Hospital 60 participants Est. completion 2027-09-30
    Type 2 diabetes Other conditions: Rifampicin-resistant/Multidrug-resistant Pulmonary Tuberculosis, Pretomanid
    View official trial listing →
  • Active, not recruiting NCT NCT07196449

    Drug-Drug Interaction of Rifampicin and Cyclosporine on Methotrexate Pharmacokinetics in Healthy Subjects

    Not yet reported Seoul National University Bundang Hospital 12 participants Est. completion 2026-04-14 1 site Stand-alone
    Other conditions: Drug Drug Interaction (DDI)
    View official trial listing →
  • Terminated NCT NCT07253688

    Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus

    Not yet reported Todd C. Lee MD MPH FIDSA 1 participants Est. completion 2026-09-14 1 site Stand-alone
    Other conditions: Staphylococcus Aureus Endocarditis, Prosthetic Valve Endocarditis
    View official trial listing →
  • Not yet recruiting NCT NCT07268664

    Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort

    Not yet reported Beijing Chest Hospital 120 participants Est. completion 2028-08-31 3 sites
    Other conditions: Rifampicin Resistant Tuberculosis, Pulmonary Tuberculosis, Tuberculosis, Drug-resistant Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT07330531

    Drug-drug Interaction Study of Rifampin and Anaprazole Sodium

    Not yet reported Xuanzhu Biopharmaceutical Co., Ltd. 24 participants Est. completion 2027-07-21 1 site Stand-alone
    Other conditions: Drug-drug Interaction Study
    View official trial listing →
  • Not yet recruiting NCT NCT07332325

    STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis

    Not yet reported University of Virginia 344 participants Est. completion 2029-09 4 sites Stand-alone
    Other conditions: Sepsis, Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT07420881

    Start4All - Start Taking Action for TB Diagnosis (DARE-TB)

    Not yet reported Liverpool School of Tropical Medicine 60000 participants Est. completion 2027-10-01
    Other conditions: TB - Tuberculosis
    View official trial listing →
  • Completed NCT NCT07429331

    Drug Interaction and Food Effect Study of CS0159

    Not yet reported Cascade Pharmaceuticals, Inc 32 participants Est. completion 2026-04-01 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Active, not recruiting NCT NCT07440160

    Digitally Facilitated, Integrated Community and Facility-Based Interventions: The HEART-TB Trial Protocol

    Not yet reported Arba Minch University 278 participants Est. completion 2026-12-30 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT07467252

    AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT

    Not yet reported Ministry of Health, Saudi Arabia 200 participants Est. completion 2028-06 1 site
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT07550621

    Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants

    Not yet reported MindRank AI Ltd 28 participants Est. completion 2026-06-08 1 site Stand-alone
    Other conditions: Healthy Volunteers (HV)
    View official trial listing →
  • Enrolling by invitation NCT NCT07607288

    Collect Data From Patients Receiving Standardized Anti-tuberculosis Therapy, Collect Monitoring Data, and Evaluate Treatment Efficacy and Potential Adverse Reactions.

    Beijing Chest Hospital 2215 participants Est. completion 2028-12-31 1 site
    Other conditions: Therapeutic Drug Monitoring (TDM), Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT07608172

    Short-Course Regimens for DS-PTB in AIDS Patients

    Not yet reported Shanghai Public Health Clinical Center 148 participants Est. completion 2028-12-31
    Other conditions: Tuberculosis in HIV-infected Individuals, Drug Susceptible Pulmonary Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT07631897

    Comparative Trial Between Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivudine/Tenofovir Regimens

    Not yet reported Shanghai Public Health Clinical Center 60 participants Est. completion 2028-12 Stand-alone
    Other conditions: HIV, Art Therapy, TB - Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT07668479

    Rifapentine-Based Shorter Regimens for Tuberculosis and TB Infection in Kazakhstan

    Public Union "Kazakhstan Association of Phthisiopulmonologists" 350 participants Est. completion 2027-08
    Other conditions: Tuberculosis, Tuberculosis Infection, Latent, Tuberculosis, Pulmonary, Drug Sensitive
    View official trial listing →
  • Not yet recruiting NCT NCT07675954

    A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis

    Not yet reported Seoul National University Hospital 294 participants Est. completion 2032-06 2 sites
    Other conditions: Rifampicin-Resistant Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT07677904

    Tuberculosis Clinical Registry in Europe

    Research Center Borstel 1000 participants Est. completion 2040-12 2 sites
    Other conditions: Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT07696091

    Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet

    Not yet reported Reistone Biopharma Company Limited 40 participants Est. completion 2026-09 1 site Stand-alone
    Other conditions: Non-cystic Fibrosis Bronchiectasis、Chronic Sinusitis Without Nasal Polyps、Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT07697157

    The Study on Effects of CYP3A and P-glycoprotein Inhibitor Itraconazole and CYP Enzyme Inducer Rifampin of HMPL-453 Tartrate Tablets

    Not yet reported Hutchmed 40 participants Est. completion 2025-12-31 1 site
    Other conditions: Health, Subjective
    View official trial listing →
  • Not yet recruiting NCT NCT07768111

    Clinical Study on Drug Interactions of Flonoltinib Maleate Tablets

    Not yet reported Chengdu Zenitar Biomedical Technology Co., Ltd 40 participants Est. completion 2027-01-31 1 site
    Other conditions: Drug Interaction Research
    View official trial listing →
  • Not yet recruiting NCT NCT07770217

    A Phase I Clinical Trial to Evaluate Pharmacokinetics of HS-10504

    Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 18 participants Est. completion 2026-11-29 Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Not yet recruiting NCT NCT07773610

    Study of Combinations of Novel Promising Drugs for Pulmonary Tuberculosis

    Not yet reported TASK Applied Science 135 participants Est. completion 2027-12-30 1 site
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Rifampin, Rifadin, Rifampicin

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.